» Articles » PMID: 33949941

Sleep-wake Characteristics, Daytime Sleepiness, and Glycemia in Young Adults with Type 1 Diabetes

Overview
Specialties Neurology
Psychiatry
Date 2021 May 5
PMID 33949941
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objectives: The purpose of this study was to describe objective sleep-wake characteristics and glycemia over 7-14 days in young adults with type 1 diabetes. In addition, person-level associations among objective sleep-wake characteristics (total sleep time, sleep variability, and sleep fragmentation index), daytime sleepiness, and glycemia (glycemic control and glucose variability) were examined.

Methods: In this cross-sectional study, objective sleep-wake characteristics were measured via actigraphy and glucose variability via continuous glucose monitoring over 6-14 days. At baseline, participants completed the Psychomotor Vigilance Test, the Trail Making Test, and questionnaires on daytime sleepiness, sleep quality, and sleep disturbance including sleep diaries.

Results: Forty-six participants (mean age, 22.3 ± 3.2 years) wore a wrist actigraph and underwent continuous glucose monitoring concurrently for 6-14 days. Greater sleep variability was directly associated with greater glucose variability (mean of daily differences; = .33, = .036). Higher daytime sleepiness was directly associated with greater glucose variability (mean of daily differences; = .50, = .001). The association between sleep variability and glucose variability (mean of daily differences) was no longer significant when accounting for daytime sleepiness and controlling for type 1 diabetes duration ( > .05). A higher sleep fragmentation index was associated with greater glucose variability ( = 1.27, = .010, 2 = 0.40) after controlling for type 1 diabetes duration and accounting for higher daytime sleepiness.

Conclusions: Sleep-wake variability, sleep fragmentation, daytime sleepiness, and the associations with glycemia are new dimensions to consider in young adults with type 1 diabetes. Sleep habits in this population may explain higher glucose variability, and optimizing sleep may improve overall diabetes management.

Citation: Griggs S, Hickman RL Jr, Strohl KP, Redeker NS, Crawford SL, Grey M. Sleep-wake characteristics, daytime sleepiness, and glycemia in young adults with type 1 diabetes. 2021;17(9):1865-1874.

Citing Articles

Effect of a Whole-Food Plant-Based Diet on Postprandial Sleepiness: A Pilot Study.

Polianovskaia A, Sutliffe J, Lopez N, Cheung J Am J Lifestyle Med. 2024; :15598276241262234.

PMID: 39554973 PMC: 11562320. DOI: 10.1177/15598276241262234.


Sleep Health Composite and Diabetes Symptom Burden in Young Adults With Type 1 Diabetes.

Griggs S, Armentrout B, Davey C, Hickman Jr R West J Nurs Res. 2024; 46(11):919-927.

PMID: 39345102 PMC: 11544555. DOI: 10.1177/01939459241287455.


Sleep Disturbances in Type 1 Diabetes and Mitigating Cardiovascular Risk.

Abu Irsheed G, Martyn-Nemeth P, Baron K, Reutrakul S J Clin Endocrinol Metab. 2024; 109(12):3011-3026.

PMID: 39106222 PMC: 11570394. DOI: 10.1210/clinem/dgae539.


Nocturnal hypoglycemia is associated with next day cognitive performance in adults with type 1 diabetes: Pilot data from the GluCog study.

Zuniga-Kennedy M, Wang O, Fonseca L, Cleveland M, Bulger J, Grinspoon E Clin Neuropsychol. 2024; 38(7):1627-1646.

PMID: 38380810 PMC: 11336034. DOI: 10.1080/13854046.2024.2315749.


The prevalence of excessive daytime sleepiness and associated factors in older diabetic patients.

Catikkas N, Tunc M, Soysal P Aging Clin Exp Res. 2023; 35(12):3205-3214.

PMID: 38064108 DOI: 10.1007/s40520-023-02602-9.


References
1.
Zhang C, Varvarigou V, Parks P, Gautam S, Bueno A, Malhotra A . Psychomotor vigilance testing of professional drivers in the occupational health clinic: a potential objective screen for daytime sleepiness. J Occup Environ Med. 2011; 54(3):296-302. PMC: 3742032. DOI: 10.1097/JOM.0b013e318223d3d6. View

2.
Buysse D, Reynolds 3rd C, Monk T, BERMAN S, Kupfer D . The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28(2):193-213. DOI: 10.1016/0165-1781(89)90047-4. View

3.
Gaudino E, Geisler M, Squires N . Construct validity in the Trail Making Test: what makes Part B harder?. J Clin Exp Neuropsychol. 1995; 17(4):529-35. DOI: 10.1080/01688639508405143. View

4.
Wilmot E, Choudhary P, Leelarathna L, Baxter M . Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care. Diabetes Obes Metab. 2019; 21(12):2599-2608. PMC: 6899456. DOI: 10.1111/dom.13842. View

5.
Larcher S, Gauchez A, Lablanche S, Pepin J, Benhamou P, Borel A . Impact of sleep behavior on glycemic control in type 1 diabetes: the role of social jetlag. Eur J Endocrinol. 2016; 175(5):411-9. DOI: 10.1530/EJE-16-0188. View